American Heart Journal

1. Am Heart J7 May 2026

   CorCal Outcomes: A randomized trial using the pooled cohort equation or coronary artery calcium to select statin therapy in primary prevention patients. Study design and baseline characteristics

   Trial designPrevention & lipids

2. Am Heart J6 May 2026

   Serial assessment of NT-proBNP and high-sensitivity cardiac troponin with glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes: Insights from EXSCEL

   Randomised controlled trialCardiometabolic & kidney

3. Am Heart J29 Apr 2026

   The European bifurcation club randomized trial of stepwise provisional stenting vs drug-coated balloon therapy for nonleft main true coronary bifurcations: The EBC DCB trial

   Trial designCoronary & ACS

4. Am Heart J28 Apr 2026

   Short-term outcomes of ticagrelor monotherapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction: A randomized pilot study

   Research articleCoronary & ACS

5. Am Heart J27 Apr 2026

   Direct oral anticoagulation interruption vs continuation in patients undergoing elective invasive coronary angiography or percutaneous coronary intervention: Design and rationale of the South Limburg Myocardial Infarction Study Group Trial 2 (SLIM-2)

   Trial designCoronary & ACS

6. Am Heart J25 Apr 2026

   Vasodilation, loop diuretics, or their combination in acute heart failure: Rationale and design of the randomized placebo-controlled DECONGEST-AHF trial

   Trial designHeart failure

7. Am Heart J24 Apr 2026

   Cerebral embolic protection devices for transcatheter aortic valve replacement: A meta-analysis and trial sequential analysis

   Meta-analysisValvular & structural

8. Am Heart J24 Apr 2026

   Community-based recruitment with ankle brachial index testing to identify peripheral artery disease participants for randomized clinical trials

   Cross-sectional studyAortic & peripheral

9. Am Heart J23 Apr 2026

   Rationale and design of the vericiguat in vasospastic angina (ViVA) trial: A double-blind placebo-controlled randomized cross-over study

   Trial designCoronary & ACS

10. Am Heart J23 Apr 2026

    Association between hospital ownership type and ST-segment elevation myocardial infarction outcomes: Insights from the National Readmission Database, 2016-2022

    Cohort studyCoronary & ACS

11. Am Heart J19 Apr 2026

    Validity of the International Classification of Diseases, Tenth Revision codes in diagnosing myocardial infarction subtypes

    Secondary analysisCoronary & ACS

12. Am Heart J17 Apr 2026

    External validation of organ perfusion pressure as a prognostic marker in cardiogenic shock

    Cohort studyAcute care & resuscitation

13. Am Heart J14 Apr 2026

    Advancing in-hospital mortality prediction for acute myocardial infarction: An analysis from the American Heart Association Get With The Guidelines–Coronary Artery Disease Registry

    Diagnostic or prognostic studyCoronary & ACS

14. Am Heart J13 Apr 2026

    Design and rational of the the PRACTICAL-HERO trial: A randomized trial of higher and lower doses of heparin vs placebo for elective diagnostic coronary angiography

    Trial designCoronary & ACS

15. Am Heart J6 Apr 2026

    Marshall-Plan ablation strategy versus pulmonary vein isolation in persistent atrial fibrillation: Clinical trial design

    Trial designArrhythmias & EP

16. Am Heart J3 Apr 2026

    Economic burden associated with systemic inflammation in patients with HFmrEF/HFpEF

    Cohort studyHeart failure

17. Am Heart J2 Apr 2026

    An online, predominantly plant-based, dietary intervention for improving cardiovascular risk: A randomized controlled trial in people with type 2 diabetes

    Randomised controlled trialCardiometabolic & kidney

18. Am Heart J2 Apr 2026

    Immune checkpoint inhibitor-induced myocarditis and outcomes after re-exposure

    Research articleCardio-oncology & other

19. Am Heart J2 Apr 2026

    Rationale and design of the Corrie Lipids Program: Impact of a digital health–enabled implementation initiative to improve lipid management

    Trial designPrevention & lipids

20. Am Heart J1 Apr 2026

    Optimal antiplatelet strategy in patients with advanced chronic kidney disease undergoing drug-eluting stent implantation: Design and rationale of the randomized ADAPT-CKD trial

    Trial designCoronary & ACS

21. Am Heart J30 Mar 2026

    Patient characteristics and prognostic importance of dialysis in IE—A nationwide study

    Cohort studyCardio-oncology & other

22. Am Heart J27 Mar 2026

    Design and rationale of the EMPagliflozin after Aortic Valve Replacement (EMPAVR) study: A randomized clinical trial

    Trial designValvular & structural

23. Am Heart J25 Mar 2026

    Design and rationale of the prospective, randomized, controlled trial to assess the management of moderate aortic stenosis by clinical surveillance or transcatheter aortic valve replacement: The PROGRESS Trial

    Trial designValvular & structural

24. Am Heart J25 Mar 2026

    Design and rationale of the Impella®-protected cardiac surgery trial (IMPACT): A multicenter, single-arm pilot study in high-risk cardiac surgery patients

    Trial designAcute care & resuscitation

25. Am Heart J21 Mar 2026

    Attaining LDL-cholesterol target post major coronary event: Care gap, associated factors and clinical outcomes

    Cohort studyCoronary & ACS

26. Am Heart J21 Mar 2026

    Enhancing invasive coronary function testing: Multivessel assessment of coronary microvascular dysfunction in patients with angina and no obstructive coronary artery disease (ANOCA)

    Cohort studyCoronary & ACS

27. Am Heart J21 Mar 2026

    Outcomes of implantable cardioverter-defibrillator implantation in adults with congenitally corrected transposition of great arteries

    Cohort studyCongenital

28. Am Heart J19 Mar 2026

    Comparative validation of risk scores for in-hospital complications following chronic total occlusion percutaneous coronary intervention

    Research articleCoronary & ACS

29. Am Heart J18 Mar 2026

    American Heart Association cardiovascular health metrics and cancer outcomes: A systematic review and meta-analysis

    Meta-analysisCardio-oncology & other

30. Am Heart J18 Mar 2026

    Evolution of endoscopic mitral valve surgery over a 11-year period at a high-volume center

    Research articleValvular & structural

31. Am Heart J17 Mar 2026

    Assessment of the gradient gap after TAVR with balloon and self-expandable valves: Analysis of a large patient cohort

    Cohort studyValvular & structural

32. Am Heart J10 Mar 2026

    Impact of total stent length on long-term outcomes with different newer-generation drug-eluting stent designs in ST-segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI ES randomized trial

    Secondary analysisCoronary & ACS

33. Am Heart J10 Mar 2026

    Physical rehabilitation for older patients with acute HFpEF (REHAB-HFpEF) trial: Design and rationale

    Trial designHeart failure

34. Am Heart J7 Mar 2026

    Characterization of biomarker profiles in patients with coronary artery disease: A prospective coronary computed tomography angiography study

    Cohort studyPrevention & lipids

35. Am Heart J7 Mar 2026

    Design and rationale of the clinical trial to obtain the highest efficacy of dual antiplatelet therapy after carotid artery stenting in high bleeding risk patients (CHET): A multicenter, randomized, open-label, superiority trial

    Trial designAortic & peripheral

36. Am Heart J7 Mar 2026

    A pilot randomized clinical trial of gamification to increase medication adherence

    Randomised controlled trialHypertension

37. Am Heart J7 Mar 2026

    Adults with repaired systemic biventricular congenital heart disease with a systemic left ventricle and heart failure with reduce ejection fraction

    Research articleHeart failure

38. Am Heart J7 Mar 2026

    Empagliflozin and functional aerobic capacity in individuals with increased risk of heart failure: The Empire Prevent Cardiac trial

    Randomised controlled trialCardiometabolic & kidney

39. Am Heart J4 Mar 2026

    Systemic inflammation, myocardial fibrosis, and subclinical cardiovascular disease in people living with HIV

    Cross-sectional studyCardio-oncology & other

40. Am Heart J2 Mar 2026

    Admission with heart failure or atrial fibrillation before mitral valve surgery and associated outcomes

    Cohort studyValvular & structural

All 150 Briefs in ExploreShowing Briefs 81–120 of 150, newest first